TSHA |
Taysha Gene Therapies, Inc. |
Jan 2, 2025 |
2 |
$0 |
4 |
Jan 3, 2025 |
Chief Executive Officer, Director |
VTR |
Ventas, Inc. |
May 14, 2024 |
1 |
$175K |
4 |
May 16, 2024 |
Director |
TSHA |
Taysha Gene Therapies, Inc. |
Jan 2, 2024 |
2 |
$0 |
4 |
Jan 4, 2024 |
Chief Executive Officer, Director |
TSHA |
Taysha Gene Therapies, Inc. |
Dec 14, 2023 |
1 |
$0 |
4 |
Dec 18, 2023 |
Chief Executive Officer, Director |
TSHA |
Taysha Gene Therapies, Inc. |
Aug 16, 2023 |
1 |
$400K |
4 |
Aug 16, 2023 |
Chief Executive Officer, Director |
VTR |
Ventas, Inc. |
May 16, 2023 |
1 |
$175K |
4 |
May 18, 2023 |
Director |
TSHA |
Taysha Gene Therapies, Inc. |
Dec 30, 2022 |
1 |
$0 |
4 |
Jan 4, 2023 |
Chief Executive Officer, Director |
TSHA |
Taysha Gene Therapies, Inc. |
Jun 17, 2022 |
1 |
$0 |
4 |
Jun 22, 2022 |
Director |
VTR |
Ventas, Inc. |
Apr 27, 2022 |
1 |
$175K |
4 |
Apr 29, 2022 |
Director |
DNAB |
Social Capital Suvretta Holdings Corp. II |
Sep 24, 2021 |
0 |
$0 |
3 |
Sep 24, 2021 |
Director |
TSHA |
Taysha Gene Therapies, Inc. |
Jun 17, 2021 |
1 |
$0 |
4 |
Jun 21, 2021 |
Director |
VTR |
Ventas, Inc. |
May 25, 2021 |
1 |
$0 |
4 |
May 27, 2021 |
Director |
TSHA |
Taysha Gene Therapies, Inc. |
May 20, 2021 |
1 |
$26.1K |
4 |
May 24, 2021 |
Director |